FDA Inspection 1027091 — Darko Jovic
The FDA completed an inspection of Darko Jovic on Aug 18, 2017 in Banja Luka, 78000. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 18, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Banja Luka, 78000 (Bosnia-Hercegovina)
Additional details
Clinical Investigator (CI)